{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:33:33Z","timestamp":1789475613552,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Scientific Research Project of Hunan Provincial Health Commission","award":["202215014474"],"award-info":[{"award-number":["202215014474"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-12399-4","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T07:12:13Z","timestamp":1753168333000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Analysis of postoperative prognosis of non-metastatic endometrial carcinoma under different recurrence patterns"],"prefix":"10.1038","volume":"15","author":[{"given":"Dong","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yini","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"issue":"1","key":"12399_CR1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41572-021-00324-8","volume":"7","author":"V Makker","year":"2021","unstructured":"Makker, V. et al. Endometrial cancer. Nat. Rev. Dis. Primers 7(1), 88. https:\/\/doi.org\/10.1038\/s41572-021-00324-8 (2021).","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"10333","key":"12399_CR2","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/S0140-6736(22)00323-3","volume":"399","author":"EJ Crosbie","year":"2022","unstructured":"Crosbie, E. J. et al. Endometrial cancer. Lancet 399 (10333), 1412\u20131428. https:\/\/doi.org\/10.1016\/S0140-6736(22)00323-3 (2022).","journal-title":"Lancet"},{"issue":"1","key":"12399_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.prro.2022.09.002","volume":"13","author":"MM Harkenrider","year":"2023","unstructured":"Harkenrider, M. M. et al. Radiation therapy for endometrial cancer: an American society for radiation oncology clinical practice guideline. Pract. Radiat. Oncol. 13 (1), 41\u201365. https:\/\/doi.org\/10.1016\/j.prro.2022.09.002 (2023).","journal-title":"Pract. Radiat. Oncol."},{"issue":"3","key":"12399_CR4","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s00404-019-05418-z","volume":"301","author":"I Ureyen","year":"2020","unstructured":"Ureyen, I. et al. Factors predicting recurrence in patients with stage IA endometrioid endometrial cancer: what is the importance of LVSI? Arch. Gynecol. Obstet. 301 (3), 737\u2013744. https:\/\/doi.org\/10.1007\/s00404-019-05418-z (2020).","journal-title":"Arch. Gynecol. Obstet."},{"issue":"5","key":"12399_CR5","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.3802\/jgo.2023.34.e85","volume":"34","author":"JS Berek","year":"2023","unstructured":"Berek, J. S. et al. FIGO staging of endometrial cancer: 2023. J. Gynecol. Oncol. 34 (5), e85. https:\/\/doi.org\/10.3802\/jgo.2023.34.e85 (2023).","journal-title":"J. Gynecol. Oncol."},{"key":"12399_CR6","doi-asserted-by":"publisher","unstructured":"Ma, H. et al. Body mass index at age 18 years and recent body mass index in relation to risk of breast cancer overall and ER\/PR\/HER2-defined subtypes in white women and African-American women: a pooled analysis. Breast Cancer Res. 20(1), 5. https:\/\/doi.org\/10.1186\/s13058-017-0931-5 (2018).","DOI":"10.1186\/s13058-017-0931-5"},{"key":"12399_CR7","doi-asserted-by":"publisher","unstructured":"Zhang, C. X. et al. Prognostic analysis of recurrence of stage I-III endometrial carcinoma based on clinicopathological parameters. J. Heze Med. Coll. 35(4):14\u20131838. https:\/\/doi.org\/10.3969\/j.issn.1008-4118.2023.04.004 (2023).","DOI":"10.3969\/j.issn.1008-4118.2023.04.004"},{"issue":"4","key":"12399_CR8","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.4314\/ahs.v19i4.47","volume":"19","author":"C Dane","year":"2019","unstructured":"Dane, C. & Bakir, S. The effect of myometrial invasion on prognostic factors and survival analysis in endometrial carcinoma. Afr. Health Sci. 19 (4), 3235\u20133241. https:\/\/doi.org\/10.4314\/ahs.v19i4.47 (2019).","journal-title":"Afr. Health Sci."},{"issue":"13","key":"12399_CR9","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1016\/j.ejca.2015.05.015","volume":"51","author":"T Bosse","year":"2015","unstructured":"Bosse, T. et al. Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer\u2013A pooled analysis of PORTEC 1 and 2 trials. Eur. J. Cancer. 51 (13), 1742\u20131750. https:\/\/doi.org\/10.1016\/j.ejca.2015.05.015 (2015).","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"12399_CR10","doi-asserted-by":"publisher","first-page":"108261","DOI":"10.1016\/j.ejso.2024.108261","volume":"50","author":"J Feng","year":"2024","unstructured":"Feng, J. et al. Prognostic evaluation of lymph-vascular space invasion in patients with endometrioid and non-endometrioid endometrial cancer: A multicenter study. Eur. J. Surg. Oncol. 50 (4), 108261. https:\/\/doi.org\/10.1016\/j.ejso.2024.108261 (2024).","journal-title":"Eur. J. Surg. Oncol."},{"issue":"3","key":"12399_CR11","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.brachy.2021.12.010","volume":"21","author":"LJ Lee","year":"2022","unstructured":"Lee, L. J. et al. Clinical outcomes and dosimetric predictors of toxicity for re-irradiation of vaginal recurrence of endometrial cancer. Brachytherapy 21 (3), 263\u2013272. https:\/\/doi.org\/10.1016\/j.brachy.2021.12.010 (2022).","journal-title":"Brachytherapy"},{"issue":"3","key":"12399_CR12","first-page":"565","volume":"32","author":"A Ishikawa","year":"2008","unstructured":"Ishikawa, A. et al. Expression of keratinocyte growth factor and its receptor in human endometrial cancer in Cooperation with steroid hormones. Int. J. Oncol. 32 (3), 565\u2013574 (2008).","journal-title":"Int. J. Oncol."},{"key":"12399_CR13","unstructured":"Wang, F. Analysis of influencing factors of recurrence of endometrial cancer and corresponding treatment strategy. Chin. J. Cancer, 32(05), 820\u2013822. (2017)."},{"issue":"1","key":"12399_CR14","first-page":"18","volume":"16","author":"JM Tabernero","year":"1995","unstructured":"Tabernero, J. M. et al. Endometrial cancer stages I and II. Analysis of survival and prognostic factors. Eur. J. Gynaecol. Oncol. 16 (1), 18\u201325 (1995).","journal-title":"Eur. J. Gynaecol. Oncol."},{"issue":"7","key":"12399_CR15","first-page":"523","volume":"43","author":"YL Ren","year":"2008","unstructured":"Ren, Y. L. et al. [Combined treatment and prognostic factors for stage III and IV endometrial carcinoma]. Zhonghua Fu Chan Ke Za Zhi. 43 (7), 523\u2013527 (2008). PMID: 19080517.","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"12399_CR16","unstructured":"Cao X. Analysis of prognostic factors of endometrial cancer. Chin. Natl. Folk Med., 22(08), 22\u201323 (2013) (in Chinese)."},{"issue":"11","key":"12399_CR17","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1080\/0284186X.2019.1643036","volume":"58","author":"K St\u00e5lberg","year":"2019","unstructured":"St\u00e5lberg, K. et al. Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer - a Swedish gynecologic Cancer group (SweGCG) study. Acta Oncol. 58 (11), 1628\u20131633. https:\/\/doi.org\/10.1080\/0284186X.2019.1643036 (2019).","journal-title":"Acta Oncol."},{"issue":"2","key":"12399_CR18","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.3802\/jgo.2021.32.e11","volume":"32","author":"L Tortorella","year":"2021","unstructured":"Tortorella, L. et al. Substantial lymph-vascular space invasion (LVSI) as predictor of distant relapse and poor prognosis in low-risk early-stage endometrial cancer. J. Gynecol. Oncol. 32 (2), e11. https:\/\/doi.org\/10.3802\/jgo.2021.32.e11 (2021).","journal-title":"J. Gynecol. Oncol."},{"issue":"3","key":"12399_CR19","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.ygyno.2021.09.008","volume":"163","author":"MM AlHilli","year":"2021","unstructured":"AlHilli, M. M. et al. Development and validation of a comprehensive clinical risk-scoring model for prediction of overall survival in patients with endometrioid endometrial carcinoma. Gynecol. Oncol. 163 (3), 511\u2013516. https:\/\/doi.org\/10.1016\/j.ygyno.2021.09.008 (2021).","journal-title":"Gynecol. Oncol."},{"key":"12399_CR20","doi-asserted-by":"publisher","unstructured":"Cancer Genome Atlas Research Network et al. Integrated genomic characterization of endometrial carcinoma [published correction appears in nature. 2013;500(7461):242]. Nature 497 (7447), 67\u201373. https:\/\/doi.org\/10.1038\/nature12113 (2013).","DOI":"10.1038\/nature12113"},{"issue":"2","key":"12399_CR21","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.canlet.2005.08.001","volume":"239","author":"YT Jeon","year":"2006","unstructured":"Jeon, Y. T. et al. Steroid receptor expressions in endometrial cancer: clinical significance and epidemiological implication. Cancer Lett. 239 (2), 198\u2013204. https:\/\/doi.org\/10.1016\/j.canlet.2005.08.001 (2006).","journal-title":"Cancer Lett."},{"key":"12399_CR22","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12957-015-0619-1","volume":"13","author":"Y Zhang","year":"2015","unstructured":"Zhang, Y. et al. Prognostic role of hormone receptors in endometrial cancer: a systematic review and meta-analysis. World J. Surg. Oncol. 13, 208. https:\/\/doi.org\/10.1186\/s12957-015-0619-1 (2015).","journal-title":"World J. Surg. Oncol."},{"issue":"1","key":"12399_CR23","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.3802\/jgo.2019.30.e13","volume":"30","author":"J Guan","year":"2019","unstructured":"Guan, J. et al. The prognostic significance of Estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: hormone receptors in risk stratification. J. Gynecol. Oncol. 30 (1), e13. https:\/\/doi.org\/10.3802\/jgo.2019.30.e13 (2019).","journal-title":"J. Gynecol. Oncol."},{"issue":"1","key":"12399_CR24","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1080\/01443615.2017.1328591","volume":"38","author":"D Tomica","year":"2018","unstructured":"Tomica, D. et al. Impact of oestrogen and progesterone receptor expression in the cancer cells and myometrium on survival of patients with endometrial cancer. J. Obstet. Gynaecol. 38 (1), 96\u2013102. https:\/\/doi.org\/10.1080\/01443615.2017.1328591 (2018).","journal-title":"J. Obstet. Gynaecol."},{"issue":"5","key":"12399_CR25","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/bjc.2015.35","volume":"112","author":"S Bendifallah","year":"2015","unstructured":"Bendifallah, S. et al. Just how accurate are the major risk stratification systems for early-stage endometrial cancer? Br. J. Cancer. 112 (5), 793\u2013801. https:\/\/doi.org\/10.1038\/bjc.2015.35 (2015).","journal-title":"Br. J. Cancer"},{"issue":"2","key":"12399_CR26","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/his.13338","volume":"72","author":"IC Van Gool","year":"2018","unstructured":"Van Gool, I. C. et al. Blinded histopathological characterisation of POLE exonuclease domain-mutant endometrial cancers: sheep in wolf\u2019s clothing. Histopathology 72 (2), 248\u2013258. https:\/\/doi.org\/10.1111\/his.13338 (2018).","journal-title":"Histopathology"},{"key":"12399_CR27","unstructured":"WHO Classification of Tumours. 5th, Edition. Female Genital Tumours (International Agency for Research on Cancer, Lyon, 2020)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12399-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12399-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12399-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T07:12:20Z","timestamp":1753168340000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12399-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,21]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12399"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-12399-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,21]]},"assertion":[{"value":"20 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in accordance with the Helsinki Declaration and approved by the Ethics Committee of the First Affiliated Hospital of the University of South China. Participant information is confidential. The need for informed consent was waived by the Ethics Committee of the First Affiliated Hospital of the University of South China.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"26506"}}